FDA inspection
Shilpa Medicare Limited: FDA inspection ending May 29, 2026
FDA inspection 1319542 · Dabaspet, Bengaluru
Key facts
| Inspection ID | 1319542 |
|---|---|
| Firm | Shilpa Medicare Limited |
| FEI number | 3018694237 |
| Address | Unit-Vi, Plot No. 29-A5, 4th Phase, Avverhalli Sompura Industrial Area |
| City | Dabaspet, Bengaluru |
| Fiscal year | 2026 |
| Inspection end date | May 29, 2026 |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data